Browsing by Subject Health Services Accessibility

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 20 of 863  next >
A67_R14-ch.pdf.jpg
2015年后发展议程中的卫生问题
世界卫生大会, 67 ( 2014 )
A67_20-ch.pdf.jpg
2015年后发展议程中的卫生问题
世界卫生大会, 67 ( 2014 )
A66_47-ch.pdf.jpg
2015年后发展议程中的卫生问题 : 秘书处的报告
世界卫生大会 66 ( 2013 )
A66_R11-ch.pdf.jpg
2015年后联合国发展议程中的卫生问题
世界卫生大会 66 ( 2013 )
A67_R21-sp.pdf.jpg
Acceso a los productos bioterapéuticos incluidos los productos bioterapéuticos similares y garantía de su calidad, seguridad y eficacia
Asamblea Mundial de la Salud, 67 ( 2014 )
B134_R19-sp.pdf.jpg
Acceso a los productos bioterapéuticos y garantía de su calidad, seguridad y eficacia
Consejo Ejecutivo, 134 ( 2014 )
B134_R19-en.pdf.jpg
Access to biotherapeutic products and ensuring quality, safety and efficacy
Executive Board, 134 ( 2014 )
A67_R21-en.pdf.jpg
Access to biotherapeutic products including similar biotherapeutic products and ensuring their quality, safety and efficacy
World Health Assembly, 67 ( 2014 )
E60946.pdf.jpg
Access to drugs in the Newly Independent States : towards sharing the patient's burden : report on a WHO seminar, London, United Kingdom 13-14 October 1997
World Health Organization. Regional Office for Europe ( 1998 )
Abstract

The WHO Regional Office for Europe organized a Seminar for the newly independent states (NIS) to analyse the increased cost of pharmaceuticals to patients and the effect of this on access to health care and to discuss successes and failures in the various countries. The aims of the seminar were to develop strategies and programmes aimed at providing political awareness of this problem, to suggest new approaches and concepts and to make policy-makers as well as government officials aware of the effect of their decisions on the accessibility, and especially the affordability, of health care and drug treatment for the entire population. The Seminar was attended by deputy ministers of health responsible for pharmaceuticals and heads of drug regulatory agencies. The Seminar provided an overview and basic information from the NIS on the role of national authorities, hospital managers, physicians and pharmacists in improving access to drugs in hospitals and primary health care. The Seminar provided participants with different mechanisms to increase access, such as improving methods of procurement, drug selection and prescribing, budgeting, drug reimbursement and regulatory measures. Examples of successful initiatives and approaches in different NIS were presented and discussed. As a result of the Seminar, the participants became more aware of the serious consequences of the declining affordability of drugs on the access to health care and its effect on the health of the population. The complex and political character of the problem is an additional hurdle in finding sustainable solutions. Practical and feasible recommendations were given, and the implementation of these recommendations at country and intercountry level will be followed up with the assistance of the pharmaceuticals programme

E60946.pdf.jpg
Access to drugs in the Newly Independent States : towards sharing the patient's burden : report on a WHO seminar, London, United Kingdom 13-14 October 1997
World Health Organization. Regional Office for Europe ( 1998 )
Abstract

The WHO Regional Office for Europe organized a Seminar for the newly independent states (NIS) to analyse the increased cost of pharmaceuticals to patients and the effect of this on access to health care and to discuss successes and failures in the various countries. The aims of the seminar were to develop strategies and programmes aimed at providing political awareness of this problem, to suggest new approaches and concepts and to make policy-makers as well as government officials aware of the effect of their decisions on the accessibility, and especially the affordability, of health care and drug treatment for the entire population. The Seminar was attended by deputy ministers of health responsible for pharmaceuticals and heads of drug regulatory agencies. The Seminar provided an overview and basic information from the NIS on the role of national authorities, hospital managers, physicians and pharmacists in improving access to drugs in hospitals and primary health care. The Seminar provided participants with different mechanisms to increase access, such as improving methods of procurement, drug selection and prescribing, budgeting, drug reimbursement and regulatory measures. Examples of successful initiatives and approaches in different NIS were presented and discussed. As a result of the Seminar, the participants became more aware of the serious consequences of the declining affordability of drugs on the access to health care and its effect on the health of the population. The complex and political character of the problem is an additional hurdle in finding sustainable solutions. Practical and feasible recommendations were given, and the implementation of these recommendations at country and intercountry level will be followed up with the assistance of the pharmaceuticals programme

B134_R19-fr.pdf.jpg
Accès aux produits biothérapeutiques et garanties concernant la qualité, l’innocuité et l’efficacité
Conseil exécutif, 134 ( 2014 )
A67_R21-fr.pdf.jpg
Accès aux produits biothérapeutiques, y compris aux produits biothérapeutiques similaires,1 et garanties concernant leur qualité, leur innocuité et leur efficacité
Assemblée mondiale de la Santé, 67 ( 2014 )
Accès aux soins de santé
( 1989 )
WHO_V&B_02.27_fre.pdf.jpg
Accoître la couverture vaccinale au niveau du centre de santé
World Health Organization. Dept. of Vaccines and Biologicals; UNICEF ( 2002 )
A58_5-en.pdf.jpg
Achievement of health-related Millennium Development Goals: report by the Secretariat
World Health Assembly, 58 ( 2005 )
B115_5-en.pdf.jpg
Achievement of the health-related Millennium Development Goals: status report
Executive Board 115 ( 2005 )
interim_statement_eng.pdf.jpg
Achieving health equity : from root causes to fair outcomes : Commission on Social Determinants of Health, interim statement
Commission on Social Determinants of Health ( 2007 )
WHF_1998_19(4)_p362-364.pdf.jpg
Action on low immunization uptake / Marcel C. Azubuike and John E. Ehiri
Azubuike, Marcel C; Ehiri, John E ( 1998 )
9789241500876_eng.pdf.jpg
Action on the social determinants of health: learning from previous experiences
World Health Organization ( 2010 )
ea553.pdf.jpg
Address by Dr Gro Harlem Brundtland Director-General to the fifty-fifth World Health Assembly, Geneva, Monday, 13 May 2002
World Health Assembly, 55; Brundtland, Gro Harlem ( 2002 )
Showing results 1 to 20 of 863  next >